Syngo Carbon Space (VA4)
Siemens Healthineers AG · Decision date Sep 29, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 29, 2026 for K263048, Syngo Carbon Space (VA4), submitted by Siemens Healthineers AG under 21 CFR 892.2050 (medical image management and processing system, Class II, product code LLZ, radiology). The public record lists the submission as a Traditional 510(k) received August 31, 2026 and reviewed by a third party. SESE denotes 510(k) clearance, not premarket approval.
The summary describes a software-only device for display, rendering and post-processing of medical data, installed on common IT hardware that is not part of the device. The listed predicate is Syngo Carbon Space (VA30A), cleared as K230561. The comparison table records a new version, simplified indications, removal of the "Diagnostic Workspace" term, and carving out the "Physician Access" option into a separate device, Syngo Carbon Enterprise Access. The record does not quantify performance testing or describe clinical evidence.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263048
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Siemens Healthineers AG
- Product code
- LLZ
- Decision code
- SESE
- Decision date
- Sep 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Image Processing, Radiological.
- Applicant
- Siemens Healthineers AG
- Product code
- LLZ
- FDA device class
- 2
FDA decision timeline
K263048 received
Application receipt date recorded by FDA.
K263048 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LLZ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
3D Anatomical ModelK262132 | The Jacobs Institute | 510(k) clearance | Nov 5, 2026 | FDA |
LiLi DICOM Viewer (LiLi )K260454 | Elevate Imaging, Inc. | 510(k) clearance | Nov 4, 2026 | FDA |
| Canon Medical Informatics, Inc. | 510(k) clearance | Oct 29, 2026 | FDA | |
MIM KineticIDK261763 | Mim Software, Inc. | 510(k) clearance | Oct 26, 2026 | FDA |
PV-iCurve ProK261531 | Perception Vision Medical Technology Co., Ltd. | 510(k) clearance | Oct 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Siemens Healthineers AG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Forchheim
Sources and methodology
- Original FDA record: K263048
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


